This topic contains a solution. Click here to go to the answer

Author Question: Acute intermittent porphyria (AIP) patients have a deficiency of: A) Coproporphyrinogen oxidase ... (Read 26 times)

JMatthes

  • Hero Member
  • *****
  • Posts: 578
Acute intermittent porphyria (AIP) patients have a deficiency of:
 
  A) Coproporphyrinogen oxidase
  B) Protoporphyrinogen oxidase
  C) PBG deaminase
  D) Ferrochelatase

Question 2

Humans do not absorb aluminum:
 
  A) Dermally
  B) Orally
  C) Parenterally
  D) Via inhalation



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jxjsniuniu

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

Ans: C

Answer to Question 2

Ans: A




JMatthes

  • Member
  • Posts: 578
Reply 2 on: Aug 10, 2018
YES! Correct, THANKS for helping me on my review


recede

  • Member
  • Posts: 315
Reply 3 on: Yesterday
Excellent

 

Did you know?

The Centers for Disease Control and Prevention has released reports detailing the deaths of infants (younger than 1 year of age) who died after being given cold and cough medications. This underscores the importance of educating parents that children younger than 2 years of age should never be given over-the-counter cold and cough medications without consulting their physicians.

Did you know?

In the ancient and medieval periods, dysentery killed about ? of all babies before they reach 12 months of age. The disease was transferred through contaminated drinking water, because there was no way to adequately dispose of sewage, which contaminated the water.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

In 2012, nearly 24 milliion Americans, aged 12 and older, had abused an illicit drug, according to the National Institute on Drug Abuse (NIDA).

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library